WELL Health Technologies Corp (WELL) — Capital Reinvestment Ratio

Latest as of September 2025: 0.26x

WELL Health Technologies Corp (WELL) has a Capital Reinvestment Ratio of 0.26x as of September 2025, meaning it reinvests 0% of its operating cash flow (CA$75.84 Million) in capital expenditures (CA$19.39 Million). See WELL Health Technologies Corp (WELL) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.26x
Capex / Operating Cash Flow

Operating Cash Flow

CA$75.84 Million
CAD

Capital Expenditures

CA$19.39 Million
CAD

Data as of

Sep 2025
Most recent filing

WELL Health Technologies Corp Capital Reinvestment Ratio (2021–2024)

This chart tracks WELL Health Technologies Corp's Capital Reinvestment Ratio across 4 annual periods. Check WELL cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for WELL Health Technologies Corp (2021–2024)

Year-by-year Capital Reinvestment Ratio for WELL Health Technologies Corp from 2021 to 2024. For live market cap and broader valuation context, see WELL Health Technologies Corp stock valuation.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2024 1.70x CA$9.52 Million CA$16.23 Million ▲ +346.0%
2023 0.38x CA$66.44 Million CA$25.38 Million ▲ +356.7%
2022 0.08x CA$76.55 Million CA$6.40 Million ▼ -30.5%
2021 0.12x CA$22.27 Million CA$2.68 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow